The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Immunohistochemistry (IHC) Market Through 2030?
The immunohistochemistry (ihc) market size has experienced swift expansion over recent years. It is anticipated to grow from $2.76 billion in 2025 to $3.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This growth observed in the past can be ascribed to the increasing utilization of ihc in cancer diagnostics, the expansion of hospital pathology laboratories, enhanced availability of monoclonal antibodies, the rising acceptance of tissue-based diagnostics, and growing clinical research efforts.
The immunohistochemistry (IHC) market is poised for significant expansion in the coming years, with its size projected to reach $4.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This growth is primarily driven by an escalating demand for precision oncology diagnostics, the increasing adoption of AI-enabled pathology analysis, the broadening scope of biomarker-driven drug development, the expanding application of multiplex tissue profiling, and rising investments in advanced pathology infrastructure. Key developments anticipated during this timeframe include the wider adoption of automated IHC staining systems, the growing utilization of multiplex IHC techniques, the increasing integration of digital pathology platforms, the expansion of companion diagnostic applications, and a heightened focus on high-specificity antibodies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp
What Major Growth Factors Are Impacting The Immunohistochemistry (IHC) Market?
The increasing need for individualized treatments is anticipated to drive the expansion of the immunohistochemistry (IHC) market in the future. Personalized medicine refers to a healthcare strategy where medical choices, methods, interventions, and products are customized for each patient, considering their distinct genetic makeup, environmental factors, and lifestyle attributes. IHC holds a crucial position in personalized medicine because it helps identify particular protein markers, which aids in precise tumor classification and diagnosis. For example, data from February 2024, provided by the US-based non-profit research body, the Personalized Medicine Coalition, revealed that personalized medicines constituted over one-third of the novel approvals by the US Food and Drug Administration in 2023. During the same year, the FDA sanctioned 16 new personalized therapies for individuals with rare diseases, an increase from 6 approvals in 2022. Consequently, the rising demand for personalized medicines is fueling the expansion of the immunohistochemistry (IHC) market.
How Is Segment Classification Applied In The Immunohistochemistry (IHC) Market?
The immunohistochemistry (ihc) market covered in this report is segmented –
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits
What Trends Are Affecting The Growth Of The Immunohistochemistry (IHC) Market?
Leading companies in the immunohistochemistry (IHC) market are prioritizing the advancement of diagnostic accuracy through cutting-edge technologies and high-quality reagents, aiming to enhance the efficacy of tissue analysis in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is an advanced imaging platform designed for precise tissue examination, enabling researchers to move from discovery phases to clinical applications using high-resolution mass spectrometry techniques, specifically for mapping biomolecules spatially within tissues. For example, in June 2024, Bruker Corporation, a US-based company involved in developing and manufacturing scientific instruments and analytical and diagnostic solutions, launched its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. This Neoflex multiomics mass spectrometry imaging (MSI) system aims to bridge the gap from discovery imaging to clinical tissue research. It features Bruker’s 10-kHz smartbeam 3D laser, enhanced imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.
Who Are The Prominent Players Across The Immunohistochemistry (IHC) Market?
Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech
Access The Complete Immunohistochemistry (IHC) Market Report:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Which Region Contributes The Most To The Immunohistochemistry (IHC) Market?
North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Immunohistochemistry (IHC) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2026, By The Business Research Company
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunoassay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Immunotoxin Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model